Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals, Inc. has filed 494 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.

Recent SEC filings

Form Date Description
8-K 2026-06-18 Other Events
8-K 2026-05-29 Notice of Delisting or Transfer; Regulation FD Disclosure
10-Q 2026-05-08 Quarterly Report
10-K 2026-03-30 Annual Report
8-K/A 2026-03-26 Submission of Matters to a Vote of Security Holders (Amended)
8-K 2026-02-13 Departure/Appointment of Directors or Officers
8-K 2025-11-26 Departure/Appointment of Directors or Officers; Submission of Matters to a Vote of Security Holders
10-Q 2025-11-14 Quarterly Report
ARS 2025-11-05 ARS
DEF 14A 2025-11-05 Proxy Statement